Benitec Biopharma reports Q3 2026 results, advances BB-301 trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. QCOM
2. MU
3. HTZ
4. FDX
5. CBRS
6. USO
7. SPY
8. KBH
9. LAES
10. HON

Go back to Benitec Biopharma reports Q3 2026 results, advances BB-301 trial
(NASDAQ: BNTC) Delayed: 13.63 --0 (-0%)
Previous Close $13.63    52 Week High $5.64 
Open $13.63    52 Week Low $1.20 
Day High $13.63    P/E N/A 
Day Low $13.63    EPS $0.00 
Volume 1,763